That would not be raising the bar too high for patients. What ought to be done is share all the known data based on usage rates and then let patients decide if the quality of life issues are worth the cost to the patients. Every patient will have different tolerance and motivation levels in that regard. Best wishes.
Market Data 
Markets 
AI
